Pièces de résistance: The human immunodeficiency virus (HIV) can acquire drug resistance by mutating the key enzyme HIV protease that is being used as a drug target. A strategy has been developed to predict drug resistance that focuses on the fact that the virus must retain reasonable efficiency for its catalytic reaction while reducing its affinity to the given drug (γM: vitality values for the mutant protein M, Ki: inhibition constant).
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.